clinafloxacin has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA | 1 |
| Abel, R; Bron, NJ; Hounslow, NJ; Koup, JR; Randinitis, EJ; Rausch, G; Sedman, AJ; Vassos, AB | 1 |
1 trial(s) available for clinafloxacin and Kidney Diseases
| Article | Year |
|---|---|
Clinafloxacin pharmacokinetics in subjects with various degrees of renal function.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis | 2001 |
1 other study(ies) available for clinafloxacin and Kidney Diseases
| Article | Year |
|---|---|
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome | 1998 |